Axsome Therapeutics (AXSM) Goodwill & Intangibles (2022 - 2026)

Axsome Therapeutics has disclosed Goodwill & Intangibles across 5 years of filings, most recently posting $51.0 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $51.0 million, down 32.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.0 million (down 32.73% YoY), and the FY2025 annual result was $75.8 million, up 28.78% from the prior year.
• Goodwill & Intangibles came in at $51.0 million for Q1 2026 at Axsome Therapeutics, down from $75.8 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $75.8 million in Q3 2025 to a low of $51.0 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $72.8 million (2022), against an average of $69.7 million.
• Across the five-year window, Goodwill & Intangibles grew 28.78% in 2025 and sank 32.73% in 2026, its largest moves.
• Axsome Therapeutics' Goodwill & Intangibles stood at $70.0 million in 2022, then declined by 6.7% to $65.3 million in 2023, then fell by 9.79% to $58.9 million in 2024, then gained by 28.78% to $75.8 million in 2025, then plunged by 32.77% to $51.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $51.0 million (Q1 2026), $75.8 million (Q4 2025), and $75.8 million (Q3 2025), per Business Quant data.